Adolescent Inpatient Tobacco and ENDS Intervention
Study Details
Study Description
Brief Summary
The purpose of this study is to develop and evaluate an evidence-based intervention to assist adolescents and young adults with current vaping to quit vaping and smoking.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Use of electronic nicotine delivery system (ENDS), which are noncombustible tobacco products (e.g., e-cigarettes), has increased dramatically among youth and is associated with numerous adverse health outcomes as well as use of alcohol and other illicit substances. National guidelines recommend counseling to address tobacco use at every adolescent clinical visit; however, many at-risk adolescents do not routinely attend primary care. Although evidence supports treatment of tobacco use during an adult hospitalization, no interventions have been developed or tested in the pediatric hospital setting. Based on promising theoretically-based evidence from the primary care and hospital settings, we will design, iteratively refine and assess implementation of a novel tobacco and ENDS use intervention for hospitalized adolescents and young adults (AYAs). We do so by conducting a randomized controlled pilot study (n=144) with 3-month follow up to evaluate preliminary efficacy as well as implementation outcomes (i.e., acceptability, feasibility, fidelity).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Control Participants will complete the baseline survey and receive an informational brochure |
|
Experimental: Intervention Participants will complete the baseline survey, receive a behavioral health intervention supported by computerized decision support, and take an exit survey |
Behavioral: E-cigarette & Tobacco Use Treatment Intervention
The behavioral intervention includes health education on vaping health risk and outcomes, motivational interviewing, and assisted quit planning from a health educator and counseling and nicotine replacement therapy (if appropriate) provided by a physician.
|
Outcome Measures
Primary Outcome Measures
- Self-reported 30-day abstinence [3 month follow up]
Cessation verified with biochemical verification of a saliva sample
Secondary Outcome Measures
- Acceptability of intervention in pediatric inpatient hospital setting [End of study (enrollment completion)]
Ratings from participants, participants' parent, and providers on perceived acceptability (i.e., satisfaction) of the intervention
- Feasibility of intervention [End of study (enrollment completion)]
Ratings from participants, participants' parent, and providers on perceived feasibility (i.e., utility or practicability) of the intervention
- Fidelity of intervention delivered by a health educator [End of study (enrollment completion)]
Extent of fidelity achieved in intervention delivery
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Admitted to the hospital
-
Screens positive for past 30 day e-cigarette use
Exclusion Criteria:
-
Age is less than 14 years or over 21 years
-
Not comfortable speaking/reading English
-
Too ill to participate
-
Severe psychiatric illness
-
Too developmentally delayed/cognitively impaired
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Children's Mercy Hospital Kansas City
- National Institutes of Health (NIH)
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: Abbey Masonbrink, MD, MPH, Children's Mercy Kansas City
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- STUDY00002116
- 5K23DA055736-02